View in EDS

Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer.

Saved in:
Bibliographic Details
Title: Addition of an Fc-IgG induces receptor clustering and increases the in vitro efficacy and in vivo anti-tumor properties of the thrombospondin-1 type I repeats (3TSR) in a mouse model of advanced stage ovarian cancer.
Authors: Matuszewska, Kathy1 (AUTHOR), ten Kortenaar, Simone1 (AUTHOR), Pereira, Madison1 (AUTHOR), Santry, Lisa A.2 (AUTHOR), Petrik, Duncan1 (AUTHOR), Lo, Kin-Ming3 (AUTHOR), Bridle, Byram W.2 (AUTHOR), Wootton, Sarah K.2 (AUTHOR), Lawler, Jack1,4 (AUTHOR), Petrik, Jim1 (AUTHOR) jpetrik@uoguelph.ca
Source: Gynecologic Oncology. Jan2022, Vol. 164 Issue 1, p154-169. 16p.
Database: Academic Search Ultimate
Description
ISSN:00908258
DOI:10.1016/j.ygyno.2021.11.006